Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Organic & Biomolecular Chemistry|July 16, 2016
Chiral, triformylphenol-derived salen-type [4 + 6] organic cagesM Petryk, J Szymkowiak, B Gierczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphomaM L Grossbard, P S Multani, A S Freedman, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.
British Journal of Haematology|August 8, 1998
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myelomaM L Grossbard, P Fidias, J Kinsella, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II studyC D Wright, J C Wain, T J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasmsM L Grossbard, J M Lambert, V S Goldmacher, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 28, 2022
LONG-TERM RESULTS OF TREATING PATIENTS WITH OPEN FRACTURES OF LOW-LEG BONESMykola L Ankin, Taras M Petryk, Oleksander A Radomski, et al.
Pageof 4